These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4078730)

  • 41. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats.
    Iwamoto ET; Marion L
    J Pharmacol Exp Ther; 1994 Nov; 271(2):601-8. PubMed ID: 7965774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
    Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
    Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of tripelennamine alone and in combination with opiates to produce antinociception in mice.
    Hui FW; Sun CJ; Tocus EC; Hanig JP
    Life Sci; 1983 Apr; 32(14):1531-8. PubMed ID: 6835002
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of pentazocine and concomitant clonidine on opioid receptors in the rat brain.
    Ogawa N; Hirose Y; Kuroda H; Takayama H
    Acta Med Okayama; 1985 Jun; 39(3):217-20. PubMed ID: 2992233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Na(+), K(+)-ATPase in morphine-induced antinociception.
    Masocha W; Horvath G; Agil A; Ocana M; Del Pozo E; Szikszay M; Baeyens JM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1122-8. PubMed ID: 12756273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disposition of morphine in rat brain: relationship to biological activity.
    Plomp GJ; Maes RA; van Ree JM
    J Pharmacol Exp Ther; 1981 Apr; 217(1):181-8. PubMed ID: 7205651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naloxone enhances epileptogenic and behavioral effects of pentazocine in rats.
    Dirksen R; Coenen AM; van Luijtelaar EL
    Pharmacol Biochem Behav; 1991 Jun; 39(2):415-20. PubMed ID: 1946581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
    Hernández-Delgadillo GP; Cruz SL
    Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration.
    Geller EB; Hawk C; Keinath SH; Tallarida RJ; Adler MW
    J Pharmacol Exp Ther; 1983 May; 225(2):391-8. PubMed ID: 6842402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels.
    Tripathi HL; Martin BR; Aceto MD
    J Pharmacol Exp Ther; 1982 Apr; 221(1):91-6. PubMed ID: 7062295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tablets.
    Poklis A
    Drug Alcohol Depend; 1984 Oct; 14(2):135-40. PubMed ID: 6510217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pentazocine-naloxone: an "abuse proof" drug can be abused.
    Lahmeyer HW; Craig RJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):389-90. PubMed ID: 3805342
    [No Abstract]   [Full Text] [Related]  

  • 57. Pentazocine--naloxone: another "addiction-proof" drug of abuse.
    Lahmeyer HW; Craig RJ
    Int J Addict; 1987 Nov; 22(11):1163-6. PubMed ID: 3429075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased brain uptake of morphine in the presence of the antihistamine tripelennamine.
    Vadlamani NL; Pontani RB; Misra AL
    J Pharm Pharmacol; 1984 Jan; 36(1):61-3. PubMed ID: 6141270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abuse of pentazocine-naloxone combination.
    Reed DA; Schnoll SH
    JAMA; 1986 Nov; 256(18):2562-4. PubMed ID: 3773159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in forebrain, cerebellum and brain stem phospholipid patterns from mothers and newborn rats after chronic pentazocine treatment during the gestation period.
    Andres R; Cabezas JA; Llanillo M
    Ital J Biochem; 1988; 37(5):275-83. PubMed ID: 3235315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.